Clinical Research Support Center, Nakamura Clinic, Japan.
Department of Public Health and Hygiene, Yamagata University School of Medicine, Japan.
Intern Med. 2020 Nov 1;59(21):2671-2678. doi: 10.2169/internalmedicine.4975-20. Epub 2020 Jul 14.
Objective In Japan, the Specific Health Check and Guidance (Tokutei-Kenshin) program was started in 2008 to decrease the social burden related to metabolic syndrome (MetS). However, so far this program has not been found to have any impact on the mortality rate. Methods The subjects consisted of individuals who participated in the Tokutei-Kenshin in seven districts between 2008 and 2015. Using a National database of death certificates, we identified those who might have died and then further confirmed such deaths with the collaboration of the regional National Health Insurance agency and public health nurses. The diagnosis of MetS was made according to the Japanese criteria. The causes of death were classified by ICD-10. Mortality risk was evaluated after adjusting for age, sex, smoking, alcohol intake and past medical history such as stroke, heart disease and kidney disease. Results Among the total of 664,926 subjects, we identified 8,051 fatal cases by the end of 2015. The crude death rate was 1.6% for those with MetS, 1.3% for those with preliminary metabolic syndrome, and 1.1% those without MetS. In MetS, the adjusted hazard ratio (95% confidence interval) was 1.08 (1.02-1.15) for all-cause and 1.39 (1.22-1.58) for cardiovascular disease mortality when the reference was for those without MetS. Conclusion The death rate was found to be significantly higher among the participants with MetS.
2008 年,日本启动了特定健康检查和指导(Tokutei-Kenshin)计划,以降低与代谢综合征(MetS)相关的社会负担。然而,到目前为止,该计划尚未发现对死亡率有任何影响。
研究对象为 2008 年至 2015 年间参加特定健康检查和指导的七个地区的个体。我们利用国家死亡证明数据库,确定可能已经死亡的人,并与地区国家健康保险机构和公共卫生护士合作进一步确认这些死亡。代谢综合征的诊断符合日本标准。死因按 ICD-10 分类。死亡率风险在调整年龄、性别、吸烟、饮酒以及中风、心脏病和肾病等既往病史后进行评估。
在总计 664926 名受试者中,我们在 2015 年底确定了 8051 例死亡病例。代谢综合征患者的粗死亡率为 1.6%,初步代谢综合征患者为 1.3%,无代谢综合征患者为 1.1%。在代谢综合征中,全因死亡的调整后危险比(95%置信区间)为 1.08(1.02-1.15),心血管疾病死亡的调整后危险比为 1.39(1.22-1.58),以无代谢综合征为参照。
代谢综合征患者的死亡率明显更高。